Guided Therapeutics (GTHP) Invested Capital (2016 - 2025)
Guided Therapeutics (GTHP) has disclosed Invested Capital for 16 consecutive years, with -$5.4 million as the latest value for Q4 2025.
- Quarterly Invested Capital fell 25.21% to -$5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.4 million through Dec 2025, down 25.21% year-over-year, with the annual reading at -$5.4 million for FY2025, 25.21% down from the prior year.
- Invested Capital hit -$5.4 million in Q4 2025 for Guided Therapeutics, down from -$5.0 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of -$2.1 million in Q3 2022 to a low of -$7.9 million in Q1 2021.
- Historically, Invested Capital has averaged -$4.5 million across 5 years, with a median of -$4.4 million in 2024.
- Biggest five-year swings in Invested Capital: surged 70.38% in 2022 and later crashed 50.27% in 2023.
- Year by year, Invested Capital stood at -$5.4 million in 2021, then skyrocketed by 57.66% to -$2.3 million in 2022, then crashed by 41.81% to -$3.3 million in 2023, then crashed by 31.45% to -$4.3 million in 2024, then decreased by 25.21% to -$5.4 million in 2025.
- Business Quant data shows Invested Capital for GTHP at -$5.4 million in Q4 2025, -$5.0 million in Q3 2025, and -$4.9 million in Q2 2025.